Investigation of CYP 2D6 Variants and their Susceptibility to Inactivation by the Known Mechanism-based Inactivator SCH66712
Osorio, Victoria M.
MetadataShow full item record
Cytochrome P450s (CYPs) are a super family of heme-containing enzymes that in humans metabolize a variety of small molecules including drugs. Human CYP2D6 is responsible for the metabolism of ~12% of all pharmaceutical drugs and has the highest number of functional polymorphic forms among human P450s, causing a variety of phenotypic activity effects. Loss of activity can lead to adverse drug effects and drug-drug interactions. Differences in susceptibility to inactivation are also possible among the variants. SCH 66712 has been previously identified as a mechanism based inactivator of CYP2D6*1. The present study examined the susceptibility to inactivation by SCH 66712 of three CYP2D6 allelic variants with a series of distal mutations (*34, *17-2, *17-3) and one possible ultra-metabolizer (*53). An active site mutant of CYP2D6, T309A, was also studied. Metabolite assays using mass spectrometry determined that all of the variants and the modified 2D6*1 T309A were active and formed the same metabolites. Activity and inactivation assays were performed utilizing bufuralol as a reporter substrate in HPLC coupled UV detection analysis. Although variants showed overall decreased stability in activity assays, in inactivation assays all were less susceptible to inactivation by SCH 66712 when compared to the reference, CYP2D6*1. The study also supports the designation of *53 as an ultra-metabolizer as it produced nearly double the product in activity assays compared to *1 even in the presence of SCH 66712.
Showing items related by title, author, creator and subject.
Investigation of the Susceptibility to Inactivation of 2D6*1 and 2D6*53 by a Known Mechanism-Based Inactivator SCH 66712 Cho, Christi (Kalamazoo College, 2016)Cytochrome P450s (P450s) are a superfamily of heme-containing enzymes that are responsible for the metabolism of many xenobiotics and other small endogenous substrates. CYP2D6 is a major P450 enzyme studied during drug ...
Mechanism Based Inactivation of Cytochrome P450 3A4 by 5-Fluoro-2-[4-[(2-phenyl-1H- imidazol-5-yl)methyl]-1-piperazinyl]pyrimidine Bolles, Amanda K. (Kalamazoo College, 2013)Human cytochrome P450 3A4 (CYP3A4) is responsible for the metabolism of over fifty percent of pharmaceutical drugs on the market today. Inhibition of CYP3A4 can lead to adverse drug-drug interactions. 5-Fluoro-2-[4-[(2-p ...
A Novel Mutagenesis Strategy to Inactivate the Gene Encoding IgAl Protease in Neisseria gonorrhoeae for Use in the' Human Challenge Model Koymen, Hakan O. (Kalamazoo College, 1994)Immunoglobulin Al (IgAI) protease is believed to be a possible virulence factor of Neisseria gonorrhoeae. However, until this point it has been impossible to study the role of IgAl protease in vivo. To avoid the addition ...